药物发现
药品
计算机科学
药物开发
计算生物学
医学
药理学
生物信息学
生物
作者
Nurken Berdigaliyev,Mohamad Aljofan
出处
期刊:Future Medicinal Chemistry
[Newlands Press Ltd]
日期:2020-04-09
卷期号:12 (10): 939-947
被引量:210
标识
DOI:10.4155/fmc-2019-0307
摘要
A new medicine will take an average of 10–15 years and more than US$2 billion before it can reach the pharmacy shelf. Traditionally, drug discovery relied on natural products as the main source of new drug entities, but was later shifted toward high-throughput synthesis and combinatorial chemistry-based development. New technologies such as ultra-high-throughput drug screening and artificial intelligence are being heavily employed to reduce the cost and the time of early drug discovery, but they remain relatively unchanged. However, are there other potentially faster and cheaper means of drug discovery? Is drug repurposing a viable alternative? In this review, we discuss the different means of drug discovery including their advantages and disadvantages.
科研通智能强力驱动
Strongly Powered by AbleSci AI